Regulating Autologous Adult Stem Cells: The FDA Steps Up-Reference-Cited by-同舟云学术

Regulating Autologous Adult Stem Cells: The FDA Steps Up

Published:2011-11 Issue:5 Volume:9 Page:393-396
ISSN:1934-5909
Container-title:Cell Stem Cell
language:en
Short-container-title:Cell Stem Cell

Author:

Lysaght Tamra,Campbell Alastair V.

Publisher

Elsevier BV

Subject

Cell Biology,Genetics,Molecular Medicine

Reference10 articles.

1. International Stem Cell Tourism and the Need for Effective Regulation: Part II: Developing Sound Oversight Measures and Effective Patient Support

2. Food and Drug Administration. (2008). Vaccines, blood and biologics: Regenerative Sciences Inc. http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/ComplianceActivities/Enforcement/UntitledLetters/ucm091991.htm.

3. Allowing Innovative Stem Cell-Based Therapies outside of Clinical Trials: Ethical and Policy Challenges

4. New ISSCR Guidelines Underscore Major Principles for Responsible Translational Stem Cell Research

5. Monitoring and Regulating Offshore Stem Cell Clinics

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. US businesses engaged in direct-to-consumer marketing of perinatal stem cell interventions following the Food and Drug Administration's enforcement discretion era;Cytotherapy;2024-04

2. Unproven Stem Cell-Based Interventions: Addressing Patients’ Unmet Needs or Causing Patient Harms?;Philosophy and Medicine;2023

3. Recellularization of Decellularized Whole Organ Scaffolds: Elements, Progresses, and Challenges;Decellularized Materials;2021

4. Clinical evaluation of micro-fragmented adipose tissue as a treatment option for patients with meniscus tears with osteoarthritis: a prospective pilot study;International Orthopaedics;2020-10-07

5. Enhancing the Bystander and Abscopal Effects to Improve Radiotherapy Outcomes;Frontiers in Oncology;2020-01-08